Cargando…
Tissue architecture delineates field cancerization in BRAF(V600E)-induced tumor development
Cancer cells hijack developmental growth mechanisms but whether tissue morphogenesis and architecture modify tumorigenesis is unknown. Here, we characterized a new mouse model of sporadic thyroid carcinogenesis based on inducible expression of BRAF carrying a Val600 Glu (V600E) point mutation (BRAFV...
Autores principales: | Schoultz, Elin, Johansson, Ellen, Moccia, Carmen, Jakubikova, Iva, Ravi, Naveen, Liang, Shawn, Carlsson, Therese, Montelius, Mikael, Patyra, Konrad, Kero, Jukka, Paulsson, Kajsa, Fagman, Henrik, Bergo, Martin O., Nilsson, Mikael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380047/ https://www.ncbi.nlm.nih.gov/pubmed/34379110 http://dx.doi.org/10.1242/dmm.048887 |
Ejemplares similares
-
Tissue specificity of oncogenic BRAF targeted to lung and thyroid through a shared lineage factor
por: Schoultz, Elin, et al.
Publicado: (2023) -
Asynchrony of Apical Polarization, Luminogenesis, and Functional Differentiation in the Developing Thyroid Gland
por: Johansson, Ellen, et al.
Publicado: (2021) -
BRAF(V600E) protein expression and outcome from BRAF inhibitor treatment in BRAF(V600E) metastatic melanoma
por: Wilmott, J S, et al.
Publicado: (2013) -
BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas
por: Del Bufalo, Francesca, et al.
Publicado: (2018) -
The role of BRAF V600 mutation in melanoma
por: Ascierto, Paolo A, et al.
Publicado: (2012)